157 related articles for article (PubMed ID: 18617166)
21. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
22. Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis.
Ono SI
Curr Pharm Des; 2017; 23(33):5001-5009. PubMed ID: 28641540
[TBL] [Abstract][Full Text] [Related]
23. Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice.
Nagano S; Ogawa Y; Yanagihara T; Sakoda S
Neurosci Lett; 1999 Apr; 265(3):159-62. PubMed ID: 10327155
[TBL] [Abstract][Full Text] [Related]
24. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
25. Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Bush AI; Morrison BM; Morrison JH; Cherny RA; Volitakis I; Beal MF; Gordon JW
J Neurosci; 2004 Sep; 24(36):7945-50. PubMed ID: 15356208
[TBL] [Abstract][Full Text] [Related]
26. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
[TBL] [Abstract][Full Text] [Related]
27. Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis.
Ohnishi S; Ito H; Suzuki Y; Adachi Y; Wate R; Zhang J; Nakano S; Kusaka H; Ikehara S
Brain Res; 2009 Nov; 1296():216-24. PubMed ID: 19686706
[TBL] [Abstract][Full Text] [Related]
28. SK-PC-B70M alleviates neurologic symptoms in G93A-SOD1 amyotrophic lateral sclerosis mice.
Seo JS; Baek IS; Leem YH; Kim TK; Cho Y; Lee SM; Park YH; Han PL
Brain Res; 2011 Jan; 1368():299-307. PubMed ID: 20971081
[TBL] [Abstract][Full Text] [Related]
29. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
30. CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type-Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding.
Farrawell NE; Yerbury MR; Plotkin SS; McAlary L; Yerbury JJ
ACS Chem Neurosci; 2019 Mar; 10(3):1555-1564. PubMed ID: 30462490
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration.
Dardiotis E; Panayiotou E; Feldman ML; Hadjisavvas A; Malas S; Vonta I; Hadjigeorgiou G; Kyriakou K; Kyriakides T
Neurosci Lett; 2013 Aug; 548():170-5. PubMed ID: 23748038
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis.
Tokuda E; Watanabe S; Okawa E; Ono S
Neurotherapeutics; 2015 Apr; 12(2):461-76. PubMed ID: 25761970
[TBL] [Abstract][Full Text] [Related]
33. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.
Pompl PN; Ho L; Bianchi M; McManus T; Qin W; Pasinetti GM
FASEB J; 2003 Apr; 17(6):725-7. PubMed ID: 12586733
[TBL] [Abstract][Full Text] [Related]
34. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
[TBL] [Abstract][Full Text] [Related]
35. Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis.
Liu J; Shinobu LA; Ward CM; Young D; Cleveland DW
J Neurochem; 2005 May; 93(4):875-82. PubMed ID: 15857390
[TBL] [Abstract][Full Text] [Related]
36. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
37. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
38. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
39. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
